undamentalytics Newsletter

Quest Diagnostics cash flow statement

In fiscal 2025, Quest Diagnostics's operations generated $1.89bn of cash; it spent $527m on capital projects, leaving free cash flow of $1.36bn. It returned $353m in dividends and $450m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Quest Diagnostics: cash flow statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations9971,1188951,1876529448211,1161,1751,2001,2432,0052,2331,7181,2721,3341,8861,951
Depreciation and amortisation257254281287283314304249270309329361408437439493570585
Stock-based pay755472502851526979615697797777888888
Capital spending167205161182231308263293252383400418403404408425527576
Free cash flow8309137341,0054216365588239238178431,5871,8301,3148649091,3591,375
Free cash flow after stock pay7558596629553935855067548447567871,4901,7511,2377878211,2711,287
Dividends paid757165108185187212223247266286297309305314331353369
Share buybacks5007509352001,0371322245904653223533252,1991,408275151450—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: DGX vs DVADGX vs LHBTSG vs DGX

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Quest Diagnostics's SEC filings (10-K and 10-Q), retrieved October 24, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Quest Diagnostics.